FDA Letter API

Techni Med, Inc. dba The Compounder

Letter data

Company
Techni Med, Inc. dba The Compounder
Recipient
Lawrence J. Frieders | Owner and Pharmacist in Charge | Techni Med, Inc. dba The Compounder | 340 Marshall Avenue | Unit 100 | Aurora | , | IL | 60506-5649 | United States
Issue date
2020-05-05
Posted date
Not available
FDA office
Division of Pharmaceutical Quality Operations III
Subject
Not available
Product
Drugs
CMS ID
493750
Reference number
CHI-10-16
FEI
Not available
Inspection dates
Not available

Normalized citations

21 CFR: None found

21 U.S.C.: None found

Related FDA links

No related FDA letter link is present in the source index.

Full source text

CLOSEOUT LETTER Techni Med, Inc. dba The Compounder MARCS-CMS 493750 — May 05, 2020 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: UPS Next Day Reference #: CHI-10-16 Product: Drugs Recipient: Recipient Name Lawrence J. Frieders Recipient Title Owner and Pharmacist in Charge Techni Med, Inc. dba The Compounder 340 Marshall Avenue Unit 100 Aurora , IL 60506-5649 United States Issuing Office: Division of Pharmaceutical Quality Operations III United States (313) 393-8100 Dear Mr. Frieders: The U.S. Food and Drug Administration (FDA) has completed an evaluation of your firm’s corrective actions in response to our warning letter (WL #CHI-10-16) dated July 29, 2016. Based on our evaluation, it appears that you have adequately addressed the violations contained in this warning letter. You are expected to take all necessary steps to ensure compliance with the Federal Food, Drug, and Cosmetic Act and FDA’s implementing regulations. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. Sincerely, /S/ Nicholas F. Lyons Compliance Director Division of Pharmaceutical Quality Operations III Content current as of: 05/12/2020 Regulated Product(s) Drugs